Dopamine transporter genotype as a risk factor for obesity in African-American smokers

Obes Res. 2002 Dec;10(12):1232-40. doi: 10.1038/oby.2002.168.

Abstract

Objective: To assess the association between a polymorphism related to dopamine function, dopamine transport (SLC6A3), and obesity in smokers.

Research methods and procedures: Logistic regression was used to assess the relationship between this genetic polymorphism and obesity (body mass index > or = 30 kg/m(2)) from a sample of 510 smokers who smoked at least 10 cigarettes per day and who were participating in a study designed to examine genetic and nongenetic predictors of response to a pharmacological treatment.

Results: The likelihood of obesity in African Americans (N = 90) with the 10/10 SLC6A3 genotype was 5.16 times that of African Americans with 9/9 or 9/10 SLC6A3 genotypes (odds ratio = 5.16, confidence interval = 1.60 to 16.65). There was no association of the SLC6A3 genotype with obesity for non-Hispanic whites (N = 420).

Discussion: These results suggest that variants of the dopamine transporter gene may be related to obesity in African-American smokers. Possible mechanisms responsible for the association between dopamine transport and obesity in African-American smokers are discussed.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Black People*
  • Body Mass Index
  • Dopamine Plasma Membrane Transport Proteins
  • Female
  • Genetic Predisposition to Disease*
  • Genotype*
  • Humans
  • Logistic Models
  • Male
  • Membrane Glycoproteins*
  • Membrane Transport Proteins / genetics*
  • Middle Aged
  • Nerve Tissue Proteins*
  • Obesity / epidemiology
  • Obesity / genetics*
  • Odds Ratio
  • Polymorphism, Genetic
  • Risk Factors
  • Smoking / adverse effects*
  • United States / epidemiology

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • SLC6A3 protein, human